Via Pharmaceuticals secured note purchase agreement with Bay City Capital Fund
SAN FRANCISCO Despite the tough economic climate, some drug makers can still get their needed injections.
Via Pharmaceuticals, a biotechnology company that develops compounds for treating cardiovascular and metabolic diseases, announced Thursday that it entered a $10 million secured note purchase agreement with Bay City Capital Fund and one of its affiliates, borrowing $2 million and getting the opportunity to borrow an additional $8 million.
“This loan agreement reflects the continuing support and confidence of Bay City Capital in our lead program, VIA-2291, for the treatment of cardiovascular disease caused by atherosclerosis, by targeting inflammation in the blood vessel wall, an underlying cause of atherosclerosis,” Via CEO Lawrence Cohen said in a statement. “We are excited about the potential of VIA-2291, which is being demonstrated in the data from our ongoing phase 2 trials, and intend to pursue strategic opportunities to partner and collaborate with large biotechnology or pharmaceutical companies, to further develop this exciting compound.”
The Partnership for a Drug-Free America praises Obama’s ONDCP director selection
NEW YORK The Partnership for a Drug-Free America is applauding President Obama and Vice President Biden’s selection of Seattle police Chief Gil Kerlikowske as the head of the Office of National Drug Control Policy.
As the prospective director of the Office of National Drug Control Policy, Kerlikowske would oversee drug problems in the United States.
ONDCP plays a critical role in establishing federal drug policy and ensuring that government agencies work together toward common goals. The Partnership works closely with ONDCP on the National Youth Anti-Drug Media Campaign and other important public education efforts, including the recent launch of the first national campaign to curb meth use in Native communities.
“The fields of substance abuse prevention, treatment and law enforcement are fortunate to have the author of the legislation to create ONDCP, Vice President Joseph R. Biden, Jr., in the White House,” said Steve Pasierb, president PFDFA. “Like the Partnership, he understands the devastating impact of addiction on families across the country and knows that there is much work ahead to reduce the enormous costs of untreated addiction.”
The Little Clinic to provide free health screenings and assessments for patients through 2009
BRENTWOOD, Tenn. The Little Clinic has announced a free health screenings and assessments program for the remainder of 2009 that will focus on such core health issues as nutrition, preventative medicine and wellness.
“The Little Clinic understands today’s economy is impacting families in a number of ways, including how consumers prioritize their healthcare expenditures and services,” stated Lisa Loscalzo, EVP business development. “Our program is aimed at providing those important screenings and healthcare assessments that need to be performed throughout the year in order to monitor overall health. Because this program is free, The Little Clinic is helping to make sure good health can remain a focus for everyone.”
Each month of the year will focus on specific health observances, such as National Nutrition Month in March, and is aimed at raising awareness among consumers of good health practices like nutrition, preventive medicine and wellness.
As March is National Nutrition Month, screenings include blood pressure, cholesterol and, for children, a child growth percentile/body mass index evaluation. In addition, The Little Clinic will supply handouts offering tips for healthy snacking, food portioning, reading labels, understanding a child’s growth percentile and managing blood pressure and cholesterol.
The Little Clinic currently has locations inside select Publix supermarkets in Georgia and Florida; Kroger stores in Indiana, Kentucky, Tennessee, Ohio and Michigan; King Soopers in Colorado; and Fry’s Food Stores in Arizona.